Start of the Global digital.auto Initiative
9.11.2022 15:00:00 EET | Business Wire | Press release
The automotive industry is facing enormous challenges. digital.auto, the global initiative launched today as an open ecosystem, aims to drive the transformation of the industry. The initiative is bringing together manufacturers (OEMs), partners and suppliers to enable the automotive industry to establish a new, digital-first approach for the creation of next generation customer experiences and data-driven mobility services. Co-initiators of digital.auto include Robert Bosch GmbH as well as software companies Dassault Systèmes and LeanIX. The industry-wide initiative is hosted by Ferdinand-Steinbeis-Institut (FSTI) from Heilbronn as a neutral, non-profit facilitator. digital.auto is launched today at Bosch ConnectedWorld 2022 in Berlin.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221109005118/en/
Connecting approach of the digital.auto initiative (Graphic: Business Wire)
digital.auto aims to improve the adoption of digital best practices in the automotive world. Taking a very use case-centric approach, the initiative is enabling the industry to introduce and apply explorative, digital-first methods. digital.auto is not designed as a consortium of its own, but is building on the structures and processes of existing consortia, alliances and technology providers. digital.auto builds on two key pillars of automotive technology development: Software-defined Vehicle (SdV) and standardized vehicle APIs. To help ensure that these technologies can realize their full potential, digital.auto is combining existing standards with appropriate methods and processes to translate technology into business value.
Thomas Irawan, CEO, ETAS GmbH, part of co-initiator Robert Bosch GmbH: „It`s high time that we adopt a digital-first approach to the development of vehicle features. This means that vehicle architectures must be defined software- and API-first, with requirements being driven by concrete use cases. For these reasons, we are proud to help co-initiate and support the digital.auto initiative.“
digital.auto is currently focusing on the following deliverables:
SdV 101 Course: Open online course with an introduction to Software-defined Vehicle
SdV Use Cases: Public repository of digital.auto use cases to ensure early validation of SdV-related technologies based on end-user scenarios
SdV Exploration: Open collaboration platform for early-stage SdV prototyping, customer experience simulation and testing*
Value Streams: Best practice library to help OEMs to better manage the digital and physical value streams of modern automotive development*
SdV Interoperabillity: An SdV inter::op program designed to help create an open market of interoperable SdV tools, making it easier for OEMs to create best-of-breed SdV toolchains*
*integrated with use case repository
More information: http://press.digital.auto
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221109005118/en/
Contact information
Ines Weybrecht
Communications Manager
info@digital.auto
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease2.5.2026 00:28:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meeting the evolving needs of patients with myeloproliferative neoplasms (MPNs) and GVHD,” said Bill Meury, Chief Executive Officer, Incyte. “Jakafi XR offers appropriate patients and physicians a once-daily option, expanding choice without changing the well-
Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 19:08:00 EEST | Press release
A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines were switched off and everyday life took center stage. The night also celebrated the start of the new partnership between Barilla and the Visa Cash App Racing Bulls (VCARB) Formula 1® Team, a meeting of
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 13:07:00 EEST | Press release
Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the
Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 02:17:00 EEST | Press release
Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan
Grindr Nominates Three New Directors to Its Board of Directors1.5.2026 00:16:00 EEST | Press release
Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced the nomination of Rob Solomon, Lisa Gersh, and Fadi Hanna to stand for election to its Board of Directors at the Annual Meeting of Shareholders on June 2, 2026. Rob Solomon is a deeply seasoned technology CEO and operator in consumer internet and marketplaces. He has held CEO and COO roles at scaled platforms including GoFundMe, Groupon, and Kayak-predecessor SideStep, and is currently CEO of leading electric aviation company H55. Lisa Gersh is a CEO and long-tenured public company director with deep experience across consumer brands, media, and commerce. She has served on the Hasbro (NASDAQ: HAS) board since 2010 and has led businesses including Oxygen Media, GOOP, and Alexander Wang. Fadi Hanna is Chief Risk Officer at Bloomberg L.P., overseeing enterprise risk across the organization. He previously worked at J.P. Morgan and has served on the board of Immigration Equality. “Over the last few years, we bu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom